Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters











Publication year range
1.
Adv Sci (Weinh) ; : e2404186, 2024 Sep 04.
Article in English | MEDLINE | ID: mdl-39231361

ABSTRACT

Coronavirus stands for a large family of viruses characterized by protruding spikes surrounding a lipidic membrane adorned with proteins. The present study explores the adhesion of transmissible gastroenteritis coronavirus (TGEV) particles on a variety of reference solid surfaces that emulate typical virus-surface interactions. Atomic force microscopy informs about trapping effectivity and the shape of the virus envelope on each surface, revealing that the deformation of TGEV particles spans from 20% to 50% in diameter. Given this large deformation range, experimental Langmuir isotherms convey an unexpectedly moderate variation in the adsorption-free energy, indicating a viral adhesion adaptability which goes beyond the membrane. The combination of an extended Helfrich theory and coarse-grained simulations reveals that, in fact, the envelope and the spikes present complementary adsorption affinities. While strong membrane-surface interaction lead to highly deformed TGEV particles, surfaces with strong spike attraction yield smaller deformations with similar or even larger adsorption-free energies.

2.
Small ; 18(28): e2200059, 2022 07.
Article in English | MEDLINE | ID: mdl-35718881

ABSTRACT

Packing biomolecules inside virus capsids has opened new avenues for the study of molecular function in confined environments. These systems not only mimic the highly crowded conditions in nature, but also allow their manipulation at the nanoscale for technological applications. Here, green fluorescent proteins are packed in virus-like particles derived from P22 bacteriophage procapsids. The authors explore individual virus cages to monitor their emission signal with total internal reflection fluorescence microscopy while simultaneously changing the microenvironment with the stylus of atomic force microscopy. The mechanical and electronic quenching can be decoupled by ≈10% each using insulator and conductive tips, respectively. While with conductive tips the fluorescence quenches and recovers regardless of the structural integrity of the capsid, with the insulator tips quenching only occurs if the green fluorescent proteins remain organized inside the capsid. The electronic quenching is associated with the coupling of the protein fluorescence emission with the tip surface plasmon resonance. In turn, the mechanical quenching is a consequence of the unfolding of the aggregated proteins during the mechanical disruption of the capsid.


Subject(s)
Single Molecule Imaging , Viral Proteins , Capsid/chemistry , Capsid Proteins/chemistry , Green Fluorescent Proteins , Microscopy, Atomic Force , Viral Proteins/chemistry
3.
Injury ; 52 Suppl 4: S22-S26, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33678464

ABSTRACT

AIMS: To evaluate clinical and radiological results of vertically unstable pelvic fractures managed by open reduction and navigated iliosacral screws. PATIENTS AND METHODS: The study included eleven patients with complex posterior ring fractures with vertical instability admitted to our hospital and managed with CT navigated iliosacral screws. There were 7 type C1, 2 C2 and 2 C3, according to Tile classification. Three patients presented a spino-pelvic dissociation and four a vertical sacral fracture affecting the foramina (Denis 2). Vertical displacement, pelvic deformity and asymmetry were measured. Tornetta and Matta criteria were used to assess the quality of pelvic reduction. RESULTS: An excellent reduction was achieved in 9 fractures and a good reduction in two. Asymmetry index improved from 13.18 to 2.72. Deformity index improved from 0.049 to 0.010. Only two patients with a Denis 2 fracture showed secondary displacement during follow-up. Four patients presented neurological complications due to their initial injuries. Seven patients were able to resume their previous activities. CONCLUSION: CT navigated IS screws provide enough stability after an anatomic reduction of the fracture. There was no complication related to screw insertion and adequate screw positioning was achieved in all the cases.


Subject(s)
Fractures, Bone , Pelvic Bones , Bone Screws , Fracture Fixation, Internal , Fractures, Bone/diagnostic imaging , Fractures, Bone/surgery , Humans , Pelvic Bones/diagnostic imaging , Pelvic Bones/surgery , Retrospective Studies , Sacrum/diagnostic imaging , Sacrum/surgery
4.
Sci Rep ; 10(1): 2851, 2020 02 18.
Article in English | MEDLINE | ID: mdl-32071334

ABSTRACT

Epigenetic reprogramming in Acute Myeloid Leukemia (AML) leads to the aberrant activation of super enhancer (SE) landscapes that drive the expression of key oncogenes, including the oncogenic MYC pathway. These SEs have been identified as promising therapeutic targets, and have given rise to a new class of drugs, including BET protein inhibitors, which center on targeting SE activity. NR4A nuclear receptors are tumor suppressors of AML that function in part through transcriptional repression of the MYC-driven oncogenic program via mechanisms that remain unclear. Here we show that NR4A1, and the NR4A inducing drug dihydroergotamine (DHE), regulate overlapping gene expression programs in AML and repress transcription of a subset of SE-associated leukemic oncogenes, including MYC. NR4As interact with an AML-selective SE cluster that governs MYC transcription and decommissions its activation status by dismissing essential SE-bound coactivators including BRD4, Mediator and p300, leading to loss of p300-dependent H3K27 acetylation and Pol 2-dependent eRNA transcription. DHE shows similar efficacy to the BET inhibitor JQ1 at repressing SE-dependent MYC expression and AML growth in mouse xenografts. Thus, DHE induction of NR4As provides an alternative strategy to BET inhibitors to target MYC dependencies via suppression of the AML-selective SE governing MYC expression.


Subject(s)
Enhancer Elements, Genetic/genetics , Leukemia, Myeloid, Acute/drug therapy , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Proto-Oncogene Proteins c-myc/genetics , Animals , Cell Cycle Proteins/genetics , Cell Line, Tumor , Cell Proliferation/drug effects , Cellular Reprogramming/genetics , Dihydroergotamine/pharmacology , E1A-Associated p300 Protein/genetics , Epigenesis, Genetic/genetics , Gene Expression Regulation, Neoplastic/drug effects , Humans , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/pathology , Mice , Nuclear Receptor Subfamily 4, Group A, Member 1/agonists , Oncogenes/genetics , Signal Transduction/drug effects , Transcription Factors/genetics , Xenograft Model Antitumor Assays
5.
Leukemia ; 33(1): 52-63, 2019 01.
Article in English | MEDLINE | ID: mdl-29884904

ABSTRACT

NR4As are AML tumor suppressors that are frequently silenced in human acute myeloid leukemia (AML). Despite their potential as novel targets for therapeutic intervention, mechanisms of NR4A silencing and strategies for their reactivation remain poorly defined. Here we show that NR4A silencing in AML occurs through blockade of transcriptional elongation rather than epigenetic promoter silencing. By intersection of NR4A-regulated gene signatures captured upon acute, exogenous expression of NR4As in human AML cells with in silico chemical genomics screening, we identify several FDA-approved drugs including dihydroergotamine (DHE) that reactivate NR4A expression and regulate NR4A-dependent gene signatures. We show that DHE induces NR4A expression via recruitment of the super elongation complex to enable elongation of NR4A promoter paused RNA polymerase II. Finally, DHE exhibits AML selective NR4A-dependent anti-leukemic activity in cytogenetically distinct human AML cells in vitro and delays AML progression in mice revealing its potential as a novel therapeutic agent in AML.


Subject(s)
Dihydroergotamine/pharmacology , Drug Delivery Systems/methods , Gene Expression Regulation, Neoplastic/drug effects , Leukemia, Myeloid, Acute/drug therapy , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , Vasoconstrictor Agents/pharmacology , Animals , Apoptosis , Cell Proliferation , Epigenesis, Genetic , Female , Humans , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Inbred NOD , Mice, SCID , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Transcriptome , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
6.
Blood ; 131(10): 1081-1093, 2018 03 08.
Article in English | MEDLINE | ID: mdl-29343483

ABSTRACT

Members of the NR4A subfamily of nuclear receptors have complex, overlapping roles during hematopoietic cell development and also function as tumor suppressors of hematologic malignancies. We previously identified NR4A1 and NR4A3 (NR4A1/3) as functionally redundant suppressors of acute myeloid leukemia (AML) development. However, their role in hematopoietic stem cell (HSC) homeostasis remains to be disclosed. Using a conditional Nr4a1/Nr4a3 knockout mouse (CDKO), we show that codepletion of NR4A1/3 promotes acute changes in HSC homeostasis including loss of HSC quiescence, accumulation of oxidative stress, and DNA damage while maintaining stem cell regenerative and differentiation capacity. Molecular profiling of CDKO HSCs revealed widespread upregulation of genetic programs governing cell cycle and inflammation and an aberrant activation of the interferon and NF-κB signaling pathways in the absence of stimuli. Mechanistically, we demonstrate that NR4A1/3 restrict HSC proliferation in part through activation of a C/EBPα-driven antiproliferative network by directly binding to a hematopoietic-specific Cebpa enhancer and activating Cebpa transcription. In addition, NR4A1/3 occupy the regulatory regions of NF-κB-regulated inflammatory cytokines, antagonizing the activation of NF-κB signaling. Taken together, our results reveal a novel coordinate control of HSC quiescence by NR4A1/3 through direct activation of C/EBPα and suppression of activation of NF-κB-driven proliferative inflammatory responses.


Subject(s)
CCAAT-Enhancer-Binding Proteins/immunology , Cell Proliferation , DNA-Binding Proteins/immunology , Hematopoietic Stem Cells/immunology , Nerve Tissue Proteins/immunology , Nuclear Receptor Subfamily 4, Group A, Member 1/immunology , Receptors, Steroid/immunology , Receptors, Thyroid Hormone/immunology , Signal Transduction/immunology , Animals , CCAAT-Enhancer-Binding Proteins/genetics , DNA Damage , DNA-Binding Proteins/genetics , Enhancer Elements, Genetic/immunology , Hematopoietic Stem Cells/pathology , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology , Mice , Mice, Knockout , Nerve Tissue Proteins/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Oxidative Stress/genetics , Oxidative Stress/immunology , Receptors, Steroid/genetics , Receptors, Thyroid Hormone/genetics , Signal Transduction/genetics , Transcription, Genetic/immunology
7.
Cell Rep ; 21(6): 1562-1573, 2017 Nov 07.
Article in English | MEDLINE | ID: mdl-29117561

ABSTRACT

Ronin (THAP11), a DNA-binding protein that evolved from a primordial DNA transposon by molecular domestication, recognizes a hyperconserved promoter sequence to control developmentally and metabolically essential genes in pluripotent stem cells. However, it remains unclear whether Ronin or related THAP proteins perform similar functions in development. Here, we present evidence that Ronin functions within the nascent heart as it arises from the mesoderm and forms a four-chambered organ. We show that Ronin is vital for cardiogenesis during midgestation by controlling a set of critical genes. The activity of Ronin coincided with the recruitment of its cofactor, Hcf-1, and the elevation of H3K4me3 levels at specific target genes, suggesting the involvement of an epigenetic mechanism. On the strength of these findings, we propose that Ronin activity during cardiogenesis offers a template to understand how important gene programs are sustained across different cell types within a developing organ such as the heart.


Subject(s)
Heart/growth & development , Repressor Proteins/metabolism , Animals , Bradycardia/metabolism , Bradycardia/physiopathology , Cardiomyopathies/metabolism , Cardiomyopathies/physiopathology , Chromatin Immunoprecipitation , Echocardiography , Embryo, Mammalian/metabolism , Embryonic Development , Gene Expression Regulation, Developmental , Heart/diagnostic imaging , Histones/genetics , Histones/metabolism , Homeobox Protein Nkx-2.5/deficiency , Homeobox Protein Nkx-2.5/genetics , Host Cell Factor C1/genetics , Host Cell Factor C1/metabolism , Methylation , Mice , Mice, Knockout , Microscopy, Fluorescence , Myosin Heavy Chains/deficiency , Myosin Heavy Chains/genetics , Oligonucleotide Array Sequence Analysis , Promoter Regions, Genetic , Protein Binding , Repressor Proteins/genetics , Transcription Initiation Site
8.
Elife ; 5: e12175, 2016 Jan 29.
Article in English | MEDLINE | ID: mdl-26824388

ABSTRACT

Transcription is a highly stochastic process. To infer transcription kinetics for a gene-of-interest, researchers commonly compare the distribution of mRNA copy-number to the prediction of a theoretical model. However, the reliability of this procedure is limited because the measured mRNA numbers represent integration over the mRNA lifetime, contribution from multiple gene copies, and mixing of cells from different cell-cycle phases. We address these limitations by simultaneously quantifying nascent and mature mRNA in individual cells, and incorporating cell-cycle effects in the analysis of mRNA statistics. We demonstrate our approach on Oct4 and Nanog in mouse embryonic stem cells. Both genes follow similar two-state kinetics. However, Nanog exhibits slower ON/OFF switching, resulting in increased cell-to-cell variability in mRNA levels. Early in the cell cycle, the two copies of each gene exhibit independent activity. After gene replication, the probability of each gene copy to be active diminishes, resulting in dosage compensation.


Subject(s)
Cell Cycle , Gene Expression Profiling , Single-Cell Analysis , Transcription, Genetic , Animals , Embryonic Stem Cells , Mice , Nanog Homeobox Protein/biosynthesis , Nanog Homeobox Protein/genetics , Octamer Transcription Factor-3/biosynthesis , Octamer Transcription Factor-3/genetics , RNA, Messenger/analysis
9.
Neuro Oncol ; 15(7): 829-39, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23502430

ABSTRACT

BACKGROUND: The Cancer Genome Atlas (TCGA) project is a large-scale effort with the goal of identifying novel molecular aberrations in glioblastoma (GBM). METHODS: Here, we describe an in-depth analysis of gene expression data and copy number aberration (CNA) data to classify GBMs into prognostic groups to determine correlates of subtypes that may be biologically significant. RESULTS: To identify predictive survival models, we searched TCGA in 173 patients and identified 42 probe sets (P = .0005) that could be used to divide the tumor samples into 3 groups and showed a significantly (P = .0006) improved overall survival. Kaplan-Meier plots showed that the median survival of group 3 was markedly longer (127 weeks) than that of groups 1 and 2 (47 and 52 weeks, respectively). We then validated the 42 probe sets to stratify the patients according to survival in other public GBM gene expression datasets (eg, GSE4290 dataset). An overall analysis of the gene expression and copy number aberration using a multivariate Cox regression model showed that the 42 probe sets had a significant (P < .018) prognostic value independent of other variables. CONCLUSIONS: By integrating multidimensional genomic data from TCGA, we identified a specific survival model in a new prognostic group of GBM and suggest that molecular stratification of patients with GBM into homogeneous subgroups may provide opportunities for the development of new treatment modalities.


Subject(s)
Biomarkers, Tumor/genetics , Brain Neoplasms/genetics , DNA Copy Number Variations/genetics , Gene Expression Profiling , Glioblastoma/genetics , RNA, Messenger/genetics , Brain Neoplasms/classification , Brain Neoplasms/mortality , Case-Control Studies , Computational Biology , Databases, Genetic , Epithelial-Mesenchymal Transition , Gene Expression Regulation, Neoplastic , Gene Regulatory Networks , Genomics , Glioblastoma/classification , Glioblastoma/mortality , Humans , Models, Statistical , Oligonucleotide Array Sequence Analysis , Prognosis , Survival Rate
10.
J Biomed Inform ; 43(6): 998-1008, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20851208

ABSTRACT

The Cancer Genome Atlas (TCGA) is a multidisciplinary, multi-institutional effort to characterize several types of cancer. Datasets from biomedical domains such as TCGA present a particularly challenging task for those interested in dynamically aggregating its results because the data sources are typically both heterogeneous and distributed. The Linked Data best practices offer a solution to integrate and discover data with those characteristics, namely through exposure of data as Web services supporting SPARQL, the Resource Description Framework query language. Most SPARQL endpoints, however, cannot easily be queried by data experts. Furthermore, exposing experimental data as SPARQL endpoints remains a challenging task because, in most cases, data must first be converted to Resource Description Framework triples. In line with those requirements, we have developed an infrastructure to expose clinical, demographic and molecular data elements generated by TCGA as a SPARQL endpoint by assigning elements to entities of the Simple Sloppy Semantic Database (S3DB) management model. All components of the infrastructure are available as independent Representational State Transfer (REST) Web services to encourage reusability, and a simple interface was developed to automatically assemble SPARQL queries by navigating a representation of the TCGA domain. A key feature of the proposed solution that greatly facilitates assembly of SPARQL queries is the distinction between the TCGA domain descriptors and data elements. Furthermore, the use of the S3DB management model as a mediator enables queries to both public and protected data without the need for prior submission to a single data source.


Subject(s)
Atlases as Topic , Computational Biology/methods , Genome , Neoplasms/genetics , Databases, Factual , Neoplasms/classification , Semantics
11.
PLoS One ; 3(12): e4076, 2008.
Article in English | MEDLINE | ID: mdl-19115005

ABSTRACT

BACKGROUND: The Cancer Genome Atlas project (TCGA) has initiated the analysis of multiple samples of a variety of tumor types, starting with glioblastoma multiforme. The analytical methods encompass genomic and transcriptomic information, as well as demographic and clinical data about the sample donors. The data create the opportunity for a systematic screening of the components of the molecular machinery for features that may be associated with tumor formation. The wealth of existing mechanistic information about cancer cell biology provides a natural reference for the exploratory exercise. METHODOLOGY/PRINCIPAL FINDINGS: Glioblastoma multiforme DNA copy number data was generated by The Cancer Genome Atlas project for 167 patients using 227 aCGH experiments, and was analyzed to build a catalog of aberrant regions. Genome screening was performed using an information theory approach in order to quantify aberration as a deviation from a centrality without the bias of untested assumptions about its parametric nature. A novel Cancer Genome Browser software application was developed and is made public to provide a user-friendly graphical interface in which the reported results can be reproduced. The application source code and stand alone executable are available at (http://code.google.com/p/cancergenome) and (http://bioinformaticstation.org), respectively. CONCLUSIONS/SIGNIFICANCE: The most important known copy number alterations for glioblastoma were correctly recovered using entropy as a measure of aberration. Additional alterations were identified in different pathways, such as cell proliferation, cell junctions and neural development. Moreover, novel candidates for oncogenes and tumor suppressors were also detected. A detailed map of aberrant regions is provided.


Subject(s)
Gene Dosage , Glioblastoma/genetics , Comparative Genomic Hybridization , Entropy , Gene Expression Profiling/methods , Genome, Human , Glioblastoma/metabolism , Humans , Neoplasms/genetics
12.
Genet Mol Res ; 4(4): 668-74, 2005 Dec 30.
Article in English | MEDLINE | ID: mdl-16475111

ABSTRACT

Penaeid shrimps are an important resource in crustacean fisheries, representing more than the half of the gross production of shrimp worldwide. In the present study, we used a sample of wide-ranging diversity (41 shrimp species) and two mitochondrial markers (758 bp) to clarify the evolutionary relationships among Penaeidae genera. Three different methodologies of tree reconstruction were employed in the study: maximum likelihood, neighbor joining and Bayesian analysis. Our results suggest that the old Penaeus genus is monophyletic and that the inclusion of the Solenocera genus within the Penaeidae family remains uncertain. With respect to Metapenaeopsis monophyly, species of this genus appeared clustered, but with a nonsignificant bootstrap value. These results elucidate some features of the unclear evolution of Penaeidae and may contribute to the taxonomic characterization of this family.


Subject(s)
Evolution, Molecular , Genetic Variation/genetics , Mitochondria/genetics , Penaeidae/genetics , Phylogeny , Algorithms , Animals , Bayes Theorem , Electron Transport Complex I/genetics , Genetic Markers , Likelihood Functions , Penaeidae/classification , RNA, Ribosomal, 16S/genetics , Sequence Alignment/methods
SELECTION OF CITATIONS
SEARCH DETAIL